Video Experimental Relacionado
Updated: Jul 18, 2026
10:44
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
GlcNAcstatin: un inhibidor picomólar y selectivo de la O-GlcNAcase que modula los niveles intracelulares de
Helge C Dorfmueller1, Vladimir S Borodkin, Marianne Schimpl
1Division of Biological Chemistry & Molecular Microbiology, School of Life Sciences, University of Dundee, Dundee DD1 5EH, Scotland.
Journal of the American Chemical Society
|December 21, 2006
Resumen
Los investigadores desarrollaron GlcNAcstatin, un inhibidor altamente selectivo para las enzimas O-GlcNAcase. Este nuevo compuesto eleva efectivamente los niveles de O-GlcNAc, ofreciendo una poderosa herramienta para estudiar las vías de señalización celular.
Área de la Ciencia:
- La bioquímica es la bioquímica.
- Biología celular Biología celular.
- Enzimología Enzimología.
Sus antecedentes:
- La modificación postraslacional con O-GlcNAc regula los procesos celulares clave.
- O-GlcNAcase es una enzima crítica en la vía de modificación de O-GlcNAc.
- Los inhibidores existentes como PUGNAc carecen de selectividad e inhiben las enzimas relacionadas.
Objetivo del estudio:
- Diseñar y sintetizar un inhibidor novedoso y altamente selectivo del caso O-GlcNA.
- Investigar el mecanismo inhibidor y la selectividad del nuevo compuesto.
- Para validar la eficacia del compuesto en el aumento de los niveles celulares de O-GlcNAc.
Principales métodos:
- Diseño de fármacos basado en la estructura utilizando datos del complejo O-GlcNAcase-PUGNAc.
- Síntesis de un inhibidor basado en el glucoimidazol, GlcNAcstatin.
- Pruebas de inhibición enzimática y cristalografía de rayos X.
- Ensayos basados en células en líneas celulares HEK 293 y SH-SY5Y.
Principales resultados:
- GlcNAcstatin es un potente inhibidor competitivo con una potencia de 5 pM para las enzimas de la familia O-GlcNAcase.
- El inhibidor exhibe una selectividad >100,000 veces mayor que las hexosaminidasas lisosómicas humanas HexA/B.
- La cristalografía de rayos X reveló que la GlcNAcstatina imita el estado de transición en el sitio activo del caso O-GlcNA.
- GlcNAcstatin aumentó con éxito los niveles de O-GlcNAc en líneas celulares humanas.
Conclusiones:
- GlcNAcstatin es un inhibidor novedoso, altamente selectivo y potente del caso O-GlcNA.
- Este compuesto proporciona una valiosa herramienta de investigación para explorar las funciones biológicas de O-GlcNAc.
- Los hallazgos avanzan en la comprensión de la señalización de O-GlcNAc y las estrategias de inhibición de enzimas.
Videos de Conceptos Relacionados
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...
01:09GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
01:23Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
01:06Oral Hypoglycemic Agents: Glinides
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...